Cytokinetics has achieved a significant milestone with the approval of its first drug in the United States. On October 27, 2023, the U.S. Food and Drug...
Cytokinetics has achieved a significant milestone by securing its first drug approval from the U.S. Food and Drug Administration (FDA). The FDA granted clearance on January...
Cytokinetics has achieved a significant milestone with the approval of its first U.S. drug, Myqorzo, by the Food and Drug Administration (FDA). This approval, granted on...
